Ghislaine Maxwell Just Popped the Dems' Bubble on Trump and the Epstein Files
Pro-Hamas Thugs Torch Cars in Front of IDF Veteran's Home While Leaving Threatening...
The FBI Just Released Surprising Numbers About Crime Rates in America
US Army Fort Under Lockdown After Active Shooting, Multiple Casualties
Sean 'Diddy' Combs Just Reached Out to Trump – You Already Know Why
Trump Rips Chuck Schumer Over 'Extortion' As Republicans Prepare to Go Nuclear
How Democrats Rig Elections and Call it Democracy
Home Depot Hide-and-Seek: ICE Bursts Out of Trucks in LA Immigration Chase
Trump Eyes Two Kevins to Replace Powell As Fed Chair Pick Narrows
Obama Slams Texas Redistricting—but His Own Record Tells a Different Story
DHS Turns South Park Smear of ICE Agents Into Epic Recruiting Ad
Trump Admin Nixes 'Lava Ridge Wind Project'
Trump Just Hiked Up Tariffs on This Country by 25 Percent
This GOP Senator Announces Run for Governor
Warren: Mamdani's Agenda Is Our Party's Message, You Know
Tipsheet

Rand Paul Corners Fauci on Quietly Changing Gain-of-Function Definition

AP Photo/J. Scott Applewhite, Pool

Dr. Anthony Fauci is back on Capitol Hill Thursday for questioning in front of the Senate Health Committee. 

Under questioning from Dr. Rand Paul, Fauci again attempted to redefine the meaning of gain-of-function research. 

Advertisement

Fauci has repeatedly denied his agency funded dangerous gain-of-function research at the Wuhan Institute of Virology. Recently, the National Institute of Health disputed that claim

"The fifth and final progress report for Grant R01AI110964, awarded to EcoHealth Alliance, Inc. is attached with redactions only for personally identifiable information," NIH Principal Deputy Director Larence Tabak explained in a letter to Republican Congressman James Comer. "It includes data from a research project conducted during the 2018-2019 grant period using bat coronavirus genome sequences already existing in nature."

Advertisement

"The limited experiment described the final progress report provided by EcoHealth Alliance was testing if spike proteins from naturally occurring bat coronaviruses circulating in China were capable of biding to the human ACE2 receptor in a mouse model," the letter continues. "In this limited experiment, laboratory mice infected with the SHC014 W1V1 bat coronavirus became sicker than those infected with the W1V1 bat coronavirus."

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement